
### [NCIT:C4737](http://purl.obolibrary.org/obo/NCIT_C4737)
**Label:** Enteropathy-Associated T-Cell Lymphoma

**Subclasses:** [NCIT:C8680](http://purl.obolibrary.org/obo/NCIT_C8680) (Recurrent Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8685](http://purl.obolibrary.org/obo/NCIT_C8685) (Stage IV Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8683](http://purl.obolibrary.org/obo/NCIT_C8683) (Stage II Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8684](http://purl.obolibrary.org/obo/NCIT_C8684) (Stage III Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8681](http://purl.obolibrary.org/obo/NCIT_C8681) (Refractory Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8682](http://purl.obolibrary.org/obo/NCIT_C8682) (Stage I Enteropathy-Associated T-Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 54.46%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 36.97%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 36.97%


